Height Measurement in Critically Ill Children

Nutritional Status Clinical Trial

Official title:

Comparison to World Health Organization (WHO) Gold Standard of Extrapolation and Estimation Methods to Assess Length/Height in Critically Ill Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03572504
• Other study ID #: 6910
• Status: Completed
• Start date: February 26, 2018
• Est. completion date: January 21, 2019

Study information

• Verified date: April 2019
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Height/length has to be assessed accurately in critically ill children, as its value is required to assess nutritional status, to calculate nutritional requirements, to calculate body surface area (involved in drug prescriptions), and to assess pulmonary function.

The WHO has standardized practices to perform height/length measurements, but this gold standard is not applicable in critically ill children (who cannot stand and are equipped with catheters, tubes and various devices). It is not accurate to rely on previous measurements as children are continuously growing. No height/length measurement tool or method has been validated so far in this population, neither any estimation nor extrapolation methods.

The investigators aim to compare the WHO gold standard for height/length measurement to a list of other methods, validated in other children populations and currently used in the pediatric setting. We intend to compare each of them to the gold standard. The secondary objectives are to describe each height/length extrapolation or estimation method and to estimate the practical use of each method for critically ill children.

A prospective observational study is planned. 140 critically ill children admitted to pediatric intensive care unit (PICU) will be recruited.

Body segments (ulna, tibia, knee-heel, arm span) will be measured and length/height extrapolated from formulas used in different populations. Previous length/height measurements will be collected to draw growth curves and extrapolate actual length/height. Parents will be asked how tall their child is.

After PICU discharge, while the child meets WHO measurement standards, accurate length/height will be measured and compared to the results of the above mentioned techniques.

Comparison will be made in-between these results.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 140
• Est. completion date: January 21, 2019
• Est. primary completion date: January 21, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• age from 28 days to 18 years

• admitted in pediatric intensive care

• WHO standard not applicable

• parent consent

Exclusion criteria:

• expected death before discharge

• expected that the child will not meet in the near future WHO standard criteria to measure height/length

• growth > 5% height before meeting the WHO criteria

• limb abnormalities, scoliosis, retractions.

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill Child
• Height
• Length
• Nutritional Status

Intervention

Other:
• critically ill children
Compare a series of measurement or size estimation techniques to the WHO standard to identify the most reliable method (s) of pediatric resuscitation.

Locations

Country	Name	City	State
France	Hôpitaux Universitaires de Starsbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	identify the most reliable method (s) of pediatric resuscitation.	Compare a series of measurement or size estimation techniques to the WHO standard to identify the most reliable method (s) of pediatric resuscitation.	110 days